OBAGI- arbutin cream 
YS PLUS CORPORATION

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Drug Facts

Ingredients: Water, Glycerin, Cetyl Alcohol, Arbutin, PPG-2 Myristyl Ether Propionate,

Sodium Lauryl Sulfate, TEA_Salicylate, Tocopheryl Acetate, Ascorbic Acid, Lactic Acid,

Phenyl Trimethicone, Sodium Metabisulfite, BHT, Saponins, Disodium EDTA,

Methylparaben, Propylparaben

BLENDfx is a brightening cream specially formulated with Arbutin, antioxidants

and emullient to help clarify and brighten skin

DIRECTIONS:  Apply to affected area twice daily or as

directed by a physician

WARNINGS: Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions

including anaphylactic symptoms and life-threatening or less severe asthmatic episodes

in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population

is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in

nonasthmatic people.

WARNING: Keep out of reach of children

Store at controlled room temperature

15 C - 30 C (59 F - 86 F)

Arbutin 4.03 mg in 57 g

BLENDfx is a brightening cream specially formulated with Arbuton, antioxidants and

emullients to help clarify and brighten skin

copy of label
OBAGI 
arbutin cream
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:69269-830
Route of Administration TOPICAL
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ARBUTIN (UNII: C5INA23HXF) (ARBUTIN - UNII:C5INA23HXF) ARBUTIN 4.03 mg  in 57 g
Inactive Ingredients
Ingredient Name Strength
WATER (UNII: 059QF0KO0R)  
GLYCERIN (UNII: PDC6A3C0OX)  
CETYL ALCOHOL (UNII: 936JST6JCN)  
PPG-2 MYRISTYL ETHER PROPIONATE (UNII: 88R97D8U8A)  
SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
TROLAMINE SALICYLATE (UNII: H8O4040BHD)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
ASCORBIC ACID (UNII: PQ6CK8PD0R)  
LACTIC ACID, UNSPECIFIED FORM (UNII: 33X04XA5AT)  
PHENYL TRIMETHICONE (UNII: DR0K5NOJ4R)  
SODIUM DITHIONATE (UNII: RPF7Z41GAW)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:69269-830-01 57 g in 1 BOTTLE; Type 0: Not a Combination Product 10/01/2014 12/31/2015
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Unapproved drug other 10/01/2014 12/31/2015
Labeler - YS PLUS CORPORATION (843007597)

Revised: 6/2017
YS PLUS CORPORATION